Indication
Suxamethonium
2 clinical trials
2 products
Clinical trial
Median Effective Dose of Rocuronium for the Prevention of Myofibrillation Caused by the Injection of SuccinylcholineStatus: , Estimated PCD: 2023-07-30
Product
rocuroniumClinical trial
Median Effective Dose of Cisatracurium for the Prevention of Fasciculation Caused by the Injection of SuccinylcholineStatus: Recruiting, Estimated PCD: 2023-08-31
Product
Cisatracurium